Cogent Biosciences, Inc. · NASDAQ:COGT
Fairmount Funds Management LLC reported a 9.90% stake in Cogent Biosciences, Inc. (Schedule 13D/A)
Event Nov 13, 2025 · Filed Nov 17, 2025
Fairmount Funds Management LLC reported a 9.90% stake in Cogent Biosciences, Inc., 15,877,418 shares, with active intent on Nov 13, 2025. Filed Nov 17, 2025 (Schedule 13D/A).
- Stake
- 9.90%
- Shares
- 15,877,418
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Fairmount Funds Management LLC | 9.90% | 15,877,418 |
| Fairmount Healthcare Fund II GP LLC | 9.90% | 15,877,418 |
Source
Related
- Cogent Biosciences, Inc.
- Fairmount Funds Management LLC
- Cogent Biosciences, Inc. shareholders
- Schedule 13D/A · Fairmount Funds Management LLC · Mar 31, 2026
- Schedule 13D/A · Fairmount Funds Management LLC · Jan 22, 2026
- Schedule 13D/A · Fairmount Funds Management LLC · Jul 14, 2025
- Form 4 · Morris Arlene · Aug 31, 2026
- Schedule 13G/A · Deerfield Mgmt, L.P. · Aug 13, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Robbins Andrew R · May 21, 2026